Thyroid Gland Carcinoma — Trials

Thyroid Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

389 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 96
Recruiting: 39
Ph III recruiting: 5
Growth YoY: −15%
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 32.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07354698	Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery(MHI)	not yet recruiting	Phase 4	114	Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER	1	Jan 21, 2026	clinicaltrials
NCT01896479	A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer(EXAMINER)	active not recruiting	Phase 4	247	Exelixis